PT2185197T - Novas composições de solução contendo fator celular e sua utilização para o tratamento de feridas - Google Patents

Novas composições de solução contendo fator celular e sua utilização para o tratamento de feridas

Info

Publication number
PT2185197T
PT2185197T PT08827981T PT08827981T PT2185197T PT 2185197 T PT2185197 T PT 2185197T PT 08827981 T PT08827981 T PT 08827981T PT 08827981 T PT08827981 T PT 08827981T PT 2185197 T PT2185197 T PT 2185197T
Authority
PT
Portugal
Prior art keywords
containing solution
treating wounds
solution compositions
cellular factor
novel cellular
Prior art date
Application number
PT08827981T
Other languages
English (en)
Inventor
S Marshall Vivienne
A Smith Charlotte
J Trumpower Catherine
L Sing George
O Palladino Linda
Original Assignee
Noveome Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noveome Biotherapeutics Inc filed Critical Noveome Biotherapeutics Inc
Publication of PT2185197T publication Critical patent/PT2185197T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1891—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PT08827981T 2007-08-22 2008-08-08 Novas composições de solução contendo fator celular e sua utilização para o tratamento de feridas PT2185197T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96570707P 2007-08-22 2007-08-22
US12596008P 2008-04-30 2008-04-30

Publications (1)

Publication Number Publication Date
PT2185197T true PT2185197T (pt) 2019-01-21

Family

ID=40378434

Family Applications (1)

Application Number Title Priority Date Filing Date
PT08827981T PT2185197T (pt) 2007-08-22 2008-08-08 Novas composições de solução contendo fator celular e sua utilização para o tratamento de feridas

Country Status (11)

Country Link
US (11) US20090054339A1 (pt)
EP (1) EP2185197B1 (pt)
JP (1) JP2010536851A (pt)
CN (2) CN104623669A (pt)
CA (1) CA2696877A1 (pt)
CY (1) CY1120994T1 (pt)
DK (1) DK2185197T3 (pt)
ES (1) ES2702809T3 (pt)
PT (1) PT2185197T (pt)
TR (1) TR201815580T4 (pt)
WO (1) WO2009025730A1 (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007061889A2 (en) * 2005-11-17 2007-05-31 Biomimetic Therapeutics, Inc. Maxillofacial bone augmentation using rhpdgf-bb and a biocompatible matrix
EP1991282B1 (en) * 2006-02-09 2013-06-19 BioMimetic Therapeutics, LLC Compositions and methods for treating bone
US9161967B2 (en) * 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
WO2008103690A2 (en) * 2007-02-20 2008-08-28 Biomimetic Therapeutics, Inc. Prevention and treatment for osteonecrosis and osteoradionecrosis of the jaw using pdgf and a bone matrix
EP2173310A4 (en) * 2007-07-24 2011-10-26 Stemnion Inc METHODS FOR PROMOTING HAIR GROWTH
CN104623669A (zh) * 2007-08-22 2015-05-20 斯丹姆涅恩有限公司 含细胞因子溶液的新组合物
EP2620139B1 (en) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1 receptor antagonist rich solutions
US9358320B2 (en) 2008-04-25 2016-06-07 Allosource Multi-layer tissue patches
US9480549B2 (en) 2008-04-25 2016-11-01 Allosource Multi-layer tissue patches
AU2010221089A1 (en) * 2009-03-05 2011-09-15 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods for the treatment of osteochondral defects
US20100239539A1 (en) * 2009-03-23 2010-09-23 Sing George L Methods for promoting differentiation and differentiation efficiency
CN107080834A (zh) * 2010-02-22 2017-08-22 生物模拟治疗有限责任公司 用于治疗腱病的血小板衍生生长因子组合物和方法
US8313764B2 (en) 2010-06-22 2012-11-20 Stemnion, Inc. Wound healing device
US20120046601A1 (en) * 2010-08-23 2012-02-23 Sing George L Methods for delivering novel cell and cell-based compositions
CA2820445A1 (en) * 2010-12-20 2012-06-28 Stemnion, Inc. Methods for treating dental diseases, disorders, and injuries
WO2012096796A1 (en) 2011-01-10 2012-07-19 Stemnion, Inc. Methods for accelerating the healing of connective tissue injuries and disorders
CA2823705C (en) * 2011-01-18 2020-09-01 Stemnion, Inc. Wound healing device comprising protein factors adsorbed onto a suture
CA2841713A1 (en) * 2011-07-15 2013-01-24 Anthrogenesis Corporation Treatment of radiation injury using amnion derived adherent cells
US9162011B2 (en) 2011-12-19 2015-10-20 Allosource Flowable matrix compositions and methods
EP2850207B1 (en) * 2012-05-16 2017-01-04 Institut National de la Santé et de la Recherche Médicale (INSERM) Methods for the diagnosis and the treatment of familial thoracic aortic aneurysms caused by tgfb2 loss of function mutations
US20140242040A1 (en) * 2013-02-23 2014-08-28 Stemnion, Inc. Methods for preventing and/or treating nasal polyps and rhinosinusitis
US9186379B2 (en) * 2013-02-23 2015-11-17 Stemnion, Inc. Methods for preventing or treating necrotizing enterocolitis
US20140242043A1 (en) * 2013-02-23 2014-08-28 Stemnion, Inc. Methods for preventing or treating optic neuritis
US8980251B2 (en) * 2013-02-23 2015-03-17 Stemnion, Inc. Methods for preventing and treating hemorrhoids
EP2968646B1 (en) 2013-03-13 2019-05-29 AlloSource Fascia fibrous compositions and methods for their use and manufacture
US9220817B2 (en) 2013-03-13 2015-12-29 Stemnion, Inc. Medical device
KR102312720B1 (ko) 2013-03-15 2021-10-13 알로소스 연조직 회복 및 재생을 위한 세포 재배치된 콜라겐 매트릭스
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9486485B2 (en) * 2013-03-15 2016-11-08 Stemnion, Inc. Methods for treating urushiol-induced contact dermatitis
US9314487B2 (en) 2013-05-17 2016-04-19 Stemnion, Inc. Methods for treating cartilage disorders, diseases, and injuries
US20150051147A1 (en) * 2013-08-19 2015-02-19 Stemnion, Inc. Methods for treating hidradenitis suppurativa
US9636364B2 (en) 2013-12-04 2017-05-02 Stemnion, Inc. Methods for treating ocular contusion and blunt injury and traumatic injury to the optic nerve
AU2014360195B2 (en) 2013-12-06 2018-02-08 Allosource Method of drying sheets of tissue
US20150335712A1 (en) 2014-05-21 2015-11-26 Stemnion, Inc. Treatment of Diseases and Conditions Caused by Increased Vascular Permeability
CN107208025A (zh) 2014-11-25 2017-09-26 康宁股份有限公司 延续细胞培养基的材料和方法
WO2017004136A1 (en) 2015-06-30 2017-01-05 Tela Bio, Inc. Corner-lock stitch patterns
WO2017015421A1 (en) 2015-07-21 2017-01-26 Tela Bio, Inc. Compliance control stitching in substrate materials
US11077169B2 (en) 2015-07-22 2021-08-03 Temple University-Of The Commonwealth System Of Higher Education Soy-derived bioactive peptides for use in compositions and methods for wound healing, tissue engineering, and regenerative medicine
WO2017189772A1 (en) 2016-04-26 2017-11-02 Tela Bio, Inc. Hernia repair grafts having anti-adhesion barriers
US10772986B2 (en) 2017-01-26 2020-09-15 Allosource Fascia fibrous compositions and methods for their use and manufacture
US20180271914A1 (en) * 2017-03-21 2018-09-27 Noveome Biotherapeutics, Inc. Methods for Reducing the Extent of Light-induced Tissue Inflammation and Injury
KR102544417B1 (ko) 2017-03-31 2023-06-16 셀룸 바이오메디컬, 인크. 생체 적합성의 조건화된 세포 배지 조성물 및 그의 용도
KR102018609B1 (ko) * 2017-04-26 2019-09-06 이장호 중간엽 줄기세포 배양액을 포함하는 세포 또는 조직의 동결보존용 조성물
EP3761963B1 (en) 2018-03-09 2025-01-22 Tela Bio, Inc. Surgical repair graft
US11446130B2 (en) 2019-03-08 2022-09-20 Tela Bio, Inc. Textured medical textiles
US10881693B2 (en) 2019-04-09 2021-01-05 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
AU2021251785A1 (en) 2020-04-07 2022-11-03 Combangio, Inc. Lyophilized mesenchymal stem cell derived secretome and uses thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874746A (en) * 1987-12-22 1989-10-17 Institute Of Molecular Biology, Inc. Wound headling composition of TGF-alpha and PDGF
GB8803697D0 (en) * 1988-02-17 1988-03-16 Deltanine Research Ltd Clinical developments using amniotic membrane cells
DE4216341A1 (de) * 1992-05-16 1993-11-18 Roehm Gmbh Lichtstreuende Polymethacrylat-Formkörper mit hohen Temperatur- und Wetterechtheitswerten
US20030191061A1 (en) * 1994-03-31 2003-10-09 Brewitt Barbara A. Treatment methods using homeopathic preparations of growth factors
US20020192198A1 (en) * 1998-04-21 2002-12-19 Elia James P. Method for growing human organs and suborgans
JPH0912478A (ja) * 1995-04-25 1997-01-14 Fuji Yakuhin Kogyo Kk 新規な皮膚欠損症治療剤
US5612026A (en) 1996-01-25 1997-03-18 The Procter & Gamble Company Cholesterol lowering drink mix compositons
CA2253724A1 (en) * 1996-04-26 1997-11-06 Case Western Reserve University Skin regeneration using mesenchymal stem cells
US6393647B1 (en) * 2000-02-17 2002-05-28 The Libman Company Broom with mounting bracket for detachable handle
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
GB2408207A (en) * 2003-11-24 2005-05-25 Johnson & Johnson Medical Ltd Wound dressing for the controlled release of therapeutic agents comprising also an inhibitor of a protease enzyme & a linker group cleavable by such an enzyme
EP2597149A1 (en) * 2004-08-16 2013-05-29 CellResearch Corporation Pte Ltd Isolation, cultivation and uses of stem/progenitor cells
US20060222634A1 (en) * 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
US8153430B2 (en) * 2005-03-31 2012-04-10 Stemnion, Inc. Methods related to surgery
ES2387402T3 (es) * 2005-03-31 2012-09-21 Stemnion, Inc. Composiciones celulares derivadas del amnios, procedimientos de fabricación y usos de las mismas
ATE485379T1 (de) * 2005-06-16 2010-11-15 Wisconsin Alumni Res Found Zytotoxische ribonukleasevarianten
AU2006259408A1 (en) * 2005-06-17 2006-12-28 Genentech, Inc. Use of VEGF for wound healing
EP1764372B1 (en) * 2005-09-20 2009-08-12 Peter Jon Nelson Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors for treatment of cancer
US8871198B2 (en) 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
US8475788B2 (en) * 2006-06-14 2013-07-02 Stemnion, Inc. Methods of treating spinal cord injury and minimizing scarring
WO2007145889A1 (en) * 2006-06-14 2007-12-21 Stemnion, Inc. Methods of treating spinal cord injury and minimizing scarring
WO2009008928A2 (en) * 2007-04-13 2009-01-15 Stemnion, Inc. Methods for treating nervous system injury and disease
US20090004161A1 (en) * 2007-06-26 2009-01-01 Palladino Linda O Methods for treating pustular conditions of the skin
CN104623669A (zh) * 2007-08-22 2015-05-20 斯丹姆涅恩有限公司 含细胞因子溶液的新组合物

Also Published As

Publication number Publication date
US20130302307A1 (en) 2013-11-14
US8283316B2 (en) 2012-10-09
US20120225048A1 (en) 2012-09-06
EP2185197B1 (en) 2018-10-17
US20120238495A1 (en) 2012-09-20
CN101815531A (zh) 2010-08-25
US9173927B2 (en) 2015-11-03
US8198239B2 (en) 2012-06-12
CA2696877A1 (en) 2009-02-26
JP2010536851A (ja) 2010-12-02
US20120225815A1 (en) 2012-09-06
US20090054339A1 (en) 2009-02-26
US8058066B2 (en) 2011-11-15
DK2185197T3 (en) 2018-12-10
US20120101036A1 (en) 2012-04-26
EP2185197A4 (en) 2011-11-23
WO2009025730A1 (en) 2009-02-26
EP2185197A1 (en) 2010-05-19
US20150025007A1 (en) 2015-01-22
US8088732B2 (en) 2012-01-03
CN101815531B (zh) 2015-01-14
US20130040880A1 (en) 2013-02-14
US8278417B2 (en) 2012-10-02
US20100144604A1 (en) 2010-06-10
CN104623669A (zh) 2015-05-20
US8318672B2 (en) 2012-11-27
US8318665B1 (en) 2012-11-27
US20100075905A1 (en) 2010-03-25
CY1120994T1 (el) 2019-12-11
US8822415B2 (en) 2014-09-02
TR201815580T4 (tr) 2018-11-21
US8530418B2 (en) 2013-09-10
ES2702809T3 (es) 2019-03-05
US20120322731A1 (en) 2012-12-20

Similar Documents

Publication Publication Date Title
HUS2300001I1 (hu) Készítmények és alkalmazások szklerózis multiplex kezelésére
EP2078522A4 (en) COMPOSITION FOR THE TREATMENT OF ALLERGIES
SI2200431T1 (sl) Sestave in metode za zdravljenje raka
EP2121110A4 (en) BIOKOMPATIBLE WUNDAUFLAGE
EP2314278A4 (en) HAIR TREATMENT COMPOSITION
GB0723874D0 (en) Dressing
IL202015A0 (en) Methods and compositions for treating skin conditions
PL2303209T3 (pl) Stabilizator kolana
EP2610255A4 (en) NOVEL HETEROCYCLIC COMPOUND, AND COMPOSITION FOR TREATING INFLAMMATORY DISEASES USING THE SAME
IL202256A0 (en) Tissue fragment composition for the treatment of incontinence
EP2120561A4 (en) COMPOSITIONS FOR TREATING BIOFILMS, AND METHODS FOR THEIR USE
EG25849A (en) Composition for treating textile
EP3117842C0 (en) FABRIC DRESSING MATERIAL
IL209336A0 (en) Compositions for treating hyperproliferative diseases and uses thereof
GB0813040D0 (en) Compositions for use as or in wound dressings
IL219439A0 (en) Composition for promoting wound healing
PL2209458T3 (pl) Kompozycje do traktowania skóry
TWI367274B (en) Composition for fabric treatment
GB0705923D0 (en) Dressing
IL211904A0 (en) Composition for treating disese
EP2134337A4 (en) NOVEL COMPOSITION FOR TREATING BURNS
PL2124793T3 (pl) Urządzenie do leczenia ran
EP2019819A4 (en) INNOVATIVE PEPTIDE DERIVATIVES AS ANTIMICROBIAL AGENTS FOR THE TREATMENT OF INJURIES
IL208624A0 (en) Compositions for the treatment of lice
ZA201204341B (en) Pharmaceutical composition for treating gutaneous burns